AI-Guided laser zaps prostate cancer in pioneering trial
NCT ID NCT06047509
Summary
This was a small, early-stage study to see if a new laser treatment system is safe and practical for treating prostate cancer. The system uses artificial intelligence (AI) software to map the cancer and guide a laser to precisely burn away the tumor while trying to avoid damaging nearby healthy areas like the urethra. Only two men were enrolled before the study was stopped, and they were followed for safety and quality of life for up to a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095-1406, United States
Conditions
Explore the condition pages connected to this study.